| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)
|
Giorgio, Carmelo Giannitto
|
|
2006
|
51 |
3 |
p. 357-362
6 p.
|
artikel
|
| 2 |
Contents
|
|
|
2006
|
51 |
3 |
p. v-vi
nvt p.
|
artikel
|
| 3 |
COX-2 inhibitors suppress lung cancer cell growth by inducing p21 via COX-2 independent signals
|
Han, ShouWei
|
|
2006
|
51 |
3 |
p. 283-296
14 p.
|
artikel
|
| 4 |
Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients
|
Gautschi, Oliver
|
|
2006
|
51 |
3 |
p. 303-311
9 p.
|
artikel
|
| 5 |
Does high intake of fruit and vegetables improve lung cancer survival?
|
Skuladottir, Halla
|
|
2006
|
51 |
3 |
p. 267-273
7 p.
|
artikel
|
| 6 |
Editorial Board
|
|
|
2006
|
51 |
3 |
p. iii-
1 p.
|
artikel
|
| 7 |
EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib
|
Yoshimura, Naruo
|
|
2006
|
51 |
3 |
p. 363-368
6 p.
|
artikel
|
| 8 |
Erlotinib in patient with non-small cell lung cancer: Significant symptomatic improvement within a few days but without change in chest X-ray
|
Garfield, D.
|
|
2006
|
51 |
3 |
p. 389-390
2 p.
|
artikel
|
| 9 |
Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer
|
Leinonen, Tero
|
|
2006
|
51 |
3 |
p. 313-321
9 p.
|
artikel
|
| 10 |
Long-duration, weekly treatment with gemcitabine plus vinorelbine for non-small cell lung cancer: A multicenter phase II study
|
Westeel, V.
|
|
2006
|
51 |
3 |
p. 347-355
9 p.
|
artikel
|
| 11 |
Maspin gene expression is a significant prognostic factor in resected non-small cell lung cancer (NSCLC)
|
Katakura, Hiromichi
|
|
2006
|
51 |
3 |
p. 323-328
6 p.
|
artikel
|
| 12 |
Nitric oxide synthases are associated with bronchial dysplasia
|
Puhakka, Airi R.A.
|
|
2006
|
51 |
3 |
p. 275-282
8 p.
|
artikel
|
| 13 |
[No title]
|
Khan, Sarah
|
|
2006
|
51 |
3 |
p. 391-392
2 p.
|
artikel
|
| 14 |
PPAR-γ agonist increase gefitinib's antitumor activity through PTEN expression
|
Lee, Sung Yong
|
|
2006
|
51 |
3 |
p. 297-301
5 p.
|
artikel
|
| 15 |
Pre-operative plasma erythropoietin concentration and survival following surgery for non-small cell lung cancer
|
Paul, I.
|
|
2006
|
51 |
3 |
p. 329-334
6 p.
|
artikel
|
| 16 |
Promising results achieved with a combination of chemotherapy and two retinoids in patients with advanced non-small-cell lung cancer
|
Nandan, Raghu
|
|
2006
|
51 |
3 |
p. 387-388
2 p.
|
artikel
|
| 17 |
Routine once-weekly darbepoetin alfa administration is cost-effective in lung cancer patients with chemotherapy-induced anemia: A Markov analysis
|
Borget, Isabelle
|
|
2006
|
51 |
3 |
p. 369-376
8 p.
|
artikel
|
| 18 |
Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials
|
Pujol, Jean-Louis
|
|
2006
|
51 |
3 |
p. 335-345
11 p.
|
artikel
|
| 19 |
Targeting colloidal particulates to thoracic lymph nodes
|
Liu, Jiang
|
|
2006
|
51 |
3 |
p. 377-386
10 p.
|
artikel
|
Tijdschrift beschrijving